Description
A major active metabolite of flurbiprofen, (R)-flurbiprofen, and (S)-flurbiprofen; inhibits COX-1 by 94% at 1,000 µM but does not inhibit oxygenation of arachidonic acid; completely inhibits cyclooxygenation of 2-AG at 300 µM; inhibits FAAH hydrolysis of anandamide in rat brain homogenates (IC50 = 84 µM at a pH of 6)
Formal name: 2-fluoro-4′-hydroxy-α-methyl-[1,1′-biphenyl]-4-acetic acid
Synonyms:
Molecular weight: 260.3
CAS: 52807-12-2
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Product Type|Biochemicals|Small Molecule Inhibitors|Fatty Acid Metabolism||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Immunology & Inflammation|Autoimmunity|Rheumatoid Arthritis||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Toxicology|Drug Metabolism|Cytochrome P450||Research Area|Toxicology|Drug Metabolism|Drug Metabolites